Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Yee John D. — Comera Life Sciences Holdings, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Yee John D.

Yee John D.

Director at Tempest Therapeutics, Inc. · on record since Jun 17, 2026
Director at Comera Life Sciences Holdings, Inc. · on record since May 20, 2022

Insider trading activity of Yee John D.

Transactions on record: 2; since Feb 14, 2023

Open-market buys: 0

Open-market sells: 0

Companies traded: 2; last filing Jun 17, 2026

Figures computed from official regulatory filings — methodology.

Companies where Yee John D. has traded

Tempest Therapeutics, Inc.1 tx · Jun 17, 2026
Comera Life Sciences Holdings, Inc.1 tx · Feb 14, 2023

Track record of Yee John D.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Yee John D.

Co-insiders of Yee John D.

ALDRICH RICHARDTempest Therapeutics, Inc.
Angel MatthewTempest Therapeutics, Inc.
Arbet-Engels ChristopheTempest Therapeutics, Inc.
Arcudi Louis J.Tempest Therapeutics, Inc.
Banerjee Sirshendu RoopomComera Life Sciences Holdings, Inc.
BARRIS PETER JTempest Therapeutics, Inc.
BASKETT FORESTTempest Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Bessemer Venture Partners VII Institutional L.P.Tempest Therapeutics, Inc.

Bessemer Venture Partners VII L.P.Tempest Therapeutics, Inc.

BLECK CHRISTOPHER ATempest Therapeutics, Inc.

Brady Stephen RTempest Therapeutics, Inc.

Brinza Jeffery M.Tempest Therapeutics, Inc.

BVP VII SPECIAL OPPORTUNITY FUND LPTempest Therapeutics, Inc.

Campbell Michael GerardComera Life Sciences Holdings, Inc.

CAPELLO JEFFREY DTempest Therapeutics, Inc.

CHAPMAN PAUL W.D.Tempest Therapeutics, Inc.

Chappel Scott CTempest Therapeutics, Inc.

Cherington CharlesComera Life Sciences Holdings, Inc.

Clarke Dorothy JComera Life Sciences Holdings, Inc.

Couturier ChristopheTempest Therapeutics, Inc.

Cutler Joel ETempest Therapeutics, Inc.

Dable Habib JTempest Therapeutics, Inc.

Deer Management Co. LLCTempest Therapeutics, Inc.

Deer VII & Co. L.P.Tempest Therapeutics, Inc.

Deer VII & Co. Ltd.Tempest Therapeutics, Inc.

DENNY GEORGE P IIIComera Life Sciences Holdings, Inc.

Dipp MichelleTempest Therapeutics, Inc.

Dubensky Thomas W.Tempest Therapeutics, Inc.

FHM VI, L.L.C.Tempest Therapeutics, Inc.

FHM VI, L.P.Tempest Therapeutics, Inc.

Fialkow David PTempest Therapeutics, Inc.

FINCK BARBARA KComera Life Sciences Holdings, Inc.

FISHER MARYTempest Therapeutics, Inc.

Florence Anthony A. Jr.Tempest Therapeutics, Inc.

FLOWERS KIRSTENComera Life Sciences Holdings, Inc.

Frazier Healthcare VI, L.P.Tempest Therapeutics, Inc.

Freebird Investments LLCComera Life Sciences Holdings, Inc.

Freebird Partners LPComera Life Sciences Holdings, Inc.

Gallagher Carol GiltnerTempest Therapeutics, Inc.

GC Entrepreneurs Fund V, LPTempest Therapeutics, Inc.

General Catalyst GP V, LLCTempest Therapeutics, Inc.

General Catalyst Group V LPTempest Therapeutics, Inc.

General Catalyst Partners V, L.P.Tempest Therapeutics, Inc.

GILLIS JONATHANTempest Therapeutics, Inc.

Hackman Jeffrey S.Comera Life Sciences Holdings, Inc.

HALPERN JOHN DComera Life Sciences Holdings, Inc.

Halpern Katherine H.Comera Life Sciences Holdings, Inc.

Halpern Tucker R.Comera Life Sciences Holdings, Inc.

Harding DavidTempest Therapeutics, Inc.

Hedley Mary LynneTempest Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Tempest Therapeutics, Inc.	Jun 17, 2026	AwardD	25,000	0.00 USD	—	SEC
Comera Life Sciences Holdings, Inc.	Feb 14, 2023	AwardD	41,608	—	—	SEC